TAG:
anatomic pathology laboratory
Is Artificial Intelligence Ready for First Use in Anatomic Pathology?
This is an excerpt of a 2,276-word article in the April 12, 2021 issue of THE DARK REPORT (TDR). The full article is available to members of The Dark Intelligence Group. CEO SUMMARY: Use of artificial intelligence (AI) to analyze digital pathology images and aid in diagnosis—or…
Is Artificial Intelligence Ready for First Use in Anatomic Pathology?
By Robert Michel | From the Volume XXVIII No. 5 – April 12, 2021 Issue
CEO SUMMARY: Use of artifical intelligence (AI) to analyze digital pathology images and aid in diagnosis—or even in making the primary diagnosis—is much discussed. Experts in pathology regularly predict that use of AI in image analysis will transform the pathology profession. Bu…
Specimen Volume Returns at Dallas-based ProPath
By Robert Michel | From the Volume XXVII, No. 12 – August 24, 2020 Issue
CEO SUMMARY: Like other physician specialties, anatomic pathology saw a dramatic collapse in the number of daily procedures with a corresponding decline in cash flow as the COVID-19 pandemic hit with full force in March, April, and May. The good news is that the daily volume of tissue…
Proposed Medicare 2021 PFS Cuts Pathology Fees by 9%
By Robert Michel | From the Volume XXVII, No. 12 – August 24, 2020 Issue
IF THE PROPOSED MEDICARE 2012 PHYSICIAN FEE SCHEDULE (PFS) RULE—published by the Centers for Medicare and Medicaid Services (CMS) on Aug. 4—takes effect as currently written, pathology professional fees will be cut by 9%, effective Jan. 1, 2021. This was not…
To Stay Afloat, Dallas AP Group Cut Staff, Payroll
By Joseph Burns | From the Volume XXVII No. 7 – May 11, 2020 Issue
CEO SUMMARY: As early cases of COVID-19 spread in some states, pathologists at the 50-member ProPath group in Dallas prepared for a widespread outbreak by preserving cash and working with bankers and other advisors to apply for federal stimulus funding. Executives also fur…
From Mid-March, Labs Saw Big Drop in Revenue
By Joseph Burns | From the Volume XXVII No. 6 – April 20, 2020 Issue
CEO SUMMARY: In response to the coronavirus outbreak, patients stopped seeing their doctors for routine care and hospitals ceased doing elective services. With fewer test referrals, clinical labs and pathology groups were hit with a substantial decline in revenue. One of t…
Expert Sees Pros, Cons In DP and WSI Systems
By Joseph Burns | From the Volume XXVI No. 13 – September 23, 2019 Issue
CEO SUMMARY: Now that the FDA has cleared two digital pathology systems for use in primary diagnosis, a growing number of pathology groups are taking up the question of whether and when they should adopt and use a digital pathology system and whole slide imaging. One pathologist with hand…
Wake Forest Baptist Lab’s Path Errors Teach Lessons
By Joseph Burns | From the Volume XXV No. 7 – May 7, 2018 Issue
CEO SUMMARY: For medical directors and pathologists interested in improving their labs’ compliance with CLIA regulations, a report from federal and state inspectors of an inspection of the pathology lab at the Wake Forest Baptist Medical Center offers insights into what issues caught th…
CMS Report, News Stories Describe Pathology Issues
By Joseph Burns | From the Volume XXV No. 6 – April 16, 2018 Issue
CEO SUMMARY: In response to information the pathology lab staff provided to the hospital’s risk manager last fall, and following a federal Centers for Medicare and Medicaid Services inspection in February, the Wake Forest Baptist Medical Center is taking corrective action to fix serious…
December 15, 2014 Intelligence: Late-Breaking Lab News
By Robert Michel | From the Volume XXI No. 17 – December 15, 2014 Issue
In certain respects, the noted physician and healthcare strategist Eric Topol, M.D., of Scripps Healthcare in La Jolla, California, can be considered a gadfly to pathology and the laboratory medicine profession. In his latest pronouncements on patient-centered healthcare, he warned c…
CURRENT ISSUE
Volume XXXI, No. 16 – November 25, 2024
Two different federal lawsuits that challenge the authority of the federal Food and Drug Administration (FDA) to regulate laboratory developed tests (LDTs) will be combined. Plaintiffs and the government in both cases agreed to move forward on this basis.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized
The Dark Report • 21806 Briarcliff Dr • Spicewood, TX 78669
Phone: 512-264-7103 • Toll Free Number: 800-560-6363
Email: info@darkreport.com
© 2024 The Dark Report. All rights reserved.